Pfizer, Inc. recalled 0.5% Bupivacaine Hydrochloride Injection vials due to a labeling mix-up that may cause the wrong drug to be administered, according to the FDA on May 3, 2021.
How to tell if you have it
- Brand: Pfizer
- Product: 0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19)
- Packaging: 25 vials per tray (NDC 0409-1162-02)
- Lot code: EG6023
- Expiration date: 07/01/2022
- Units affected: 163,957 vials
The hazard
Some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP.
Context
GovInfoNow's records show Pfizer Inc. has 71 other recalls on record since November 26, 2012. Other recent recalls of similar products include Pfizer Epinephrine Vial Recall (August 4, 2025), Pfizer Bicillin L-A Injectable Suspension Recall (July 10, 2025), and Pfizer recalls DOBUTamine injection vials with discoloration risk (May 28, 2025). Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (August 19, 2026), Pfizer Dopamine HCl Inj Recall (September 4, 2026), and American Regent Levocarnitine Injection Recall (April 16, 2026).